Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
RSC Medicinal Chemistry|April 26, 2024
Progress in small-molecule inhibitors targeting PD-L1Jindan Xu, Yuanfang Kong, Pengbo Zhu, et al.
Chemistry, an Asian Journal|November 28, 2017
Cu(OAc)2 /TEMPO Cooperative Promoted Hydroamination Cyclization and Oxidative Dehydrogenation Cascade Reaction of Homopropargylic AminesYuanfang Kong, Kediliya Wumaier, Yingze Liu, et al.
Biomolecules|February 26, 2025
Quinazolinones as Potential Anticancer Agents: Synthesis and Action MechanismsZhijiang Deng, Jieming Li, Pengbo Zhu, et al.
Chinese Journal of Natural Medicines|December 24, 2023
Chemical approaches for the stereocontrolled synthesis of 1,2-cis-β-D-rhamnosidesJuntao Cai, Xin Yuan, Yuanfang Kong, et al.
Neuroscience|November 1, 2025
Mechanism-driven multitarget therapeutics for diabetic peripheral neuropathyShiyu Kong, Guanglei Nan, Yueyang Wang, et al.
Chemistry & Biodiversity|June 11, 2026
Advances in Quinazolinone-Based Tumor-Targeted InhibitorsJieming Li, Shuaiyi Lv, Bin Yang, et al.
Scientific Reports|May 12, 2023
Design, synthesis and anticancer activities evaluation of novel pyrazole modified catalpol derivativesYuanfang Kong, Shuanglin Liu, Shaopei Wang, et al.
Journal of Colloid and Interface Science|August 16, 2024
Rationally designed CaTiO3/Mn0.5Cd0.5S/Ni3C S-scheme/Schottky integrated heterojunction for efficient photocatalytic H2 evolutionHua Lv, Chayuan Zhou, Qinhui Shen, et al.
Pharmaceuticals (Basel, Switzerland)|October 29, 2025
Multi-Target Therapeutic Potential of Arctii Fructus Lignans in Diabetes Mellitus and Its Complications: A Mechanistic ReviewShuaiyi Lv, Jieming Li, Yulong Hu, et al.
Pageof 3